Oncogene expression in carotid body tumors

Cancer

Volumn 77, Issue 12, 1996, Pages 2581-2587

  Wang, Da Gong ^a,c   Barros D'Sa, Aaros A B ^b   Johnston, Colin F ^a   Buchanan, Keith D ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c WELLCOME RESEARCH LABORATORIES   (United Kingdom)

Author keywords

carotid body paraganglioma; immunohistochemistry; oncogene; pathogenesis

Indexed keywords

ONCOPROTEIN;

ADOLESCENT; ADULT; ARTICLE; CARCINOGENESIS; CAROTID BODY TUMOR; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE; ONCOGENE C JUN; ONCOGENE C MYC; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CAROTID BODY TUMOR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ERBB-2;

EID: 9344224009     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960615)77:12<2581::AID-CNCR23>3.0.CO;2-N     Document Type: Article

References (48)

1. Peterson EW, Meeker LH. Tumors of the carotid body. Ann Surg 1936;103:554-67.
2. Byrne JJ. Carotid body and allied tumors. Ann J Surg 1958;95:371-5.
3. Pryse-Davies J, Dawaon IMP, Westbury G. Some morphologic, histochemical, and chemical observations on chemodectomas and the normal carotid body, including a study of the chromaffin reaction and possible ganglion cell elements. Cancer 1964;17:185-202.
4. Saldana MJ, Salem LE, Travezan R. High altitude hypoxia and chemodectomas. Hum Physiol 1973;4:251-63.
5. Arias-Stella J, Valcarcei J. Chief cell hyperplasia in the human carotid body at high altitudes. Hum Physiol 1976;7:361-73.
6. Barros D'Sa AAB. Management of carotid body tumours. Curr Prac Surg 1992;4:36-48.
7. Hamilton JRL, Barros D'Sa AAB. Radionuclide angiography and surgery for familial bilateral chemodectomas. Eur J Vasc Surg 1987;1:97-105.
8. Weinstein IB. The origins of human cancer: molecular mechanisms of carcinogenesis and their implication for cancer prevention and treatment. 27th GHA clowes memorial award lecture. Cancer Res 1989;48:4135-43.
9. Wang DG, Johnston CF, Anderson N, Sloan JM, Buchanan KD. Over-expression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis. J Pathol 1995;175:397-401.
10. Cole MD. The myc oncogene: its role in transformation and differentiation. Annu Rev Genet 1986;20:361-84.
11. Goto K, Ogo A, Yanase T, Haji M, Ohashi M, Nawata H. Expression of c-fos and c-myc proto-oncogene in human adrenal pheochromocytomas. J Clin Endocrinol Metab 1990;70:353-7.
12. Roncalli M, Springall DR, Varndell IM, Gaitonde W, Hamid Q, Ibrahim NBN, et al. Oncoprotein immunoreactivity in human endocrine tumour. J Pathol 1991;163:117-27.
13. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death, Nature 1990;348:334-6.
14. Reed JC, Meister L, Tanaka S, Cuddy M, Yun S, Geyer C, et al. Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell line of neural origin. Cancer Res 1991;51:6529-38.
15. Zhong LT, Sarafian T, Kane DJ, Charles AC, Mah SP, Edwards RH, et al. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993;90:4533-7.
16. Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Toclaro GT, et al. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci USA 1990;87:4905-9.
17. Vogt P, Tjian R. jun: a transcriptional regulator turned oncogeneic. Oncogene 1988;3:3-7.
18. Tiniakos DG, Scott LE, Corbett IP, Piggott NH, Hornec H. Studies of c-Jun oncogene expression in human breast using a new monoclonal antibody, NCL-DK4. J Pathol 1994;172:19-26.
19. Magrisso IJ, Richnond RE, Carter JH, Pross CB, Gilfillen RA, Carter HW. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Lab Invest 1993;69:674-81.
20. Kliewer KE, Cochran AJ. A review of histology, ultrastructure, immunohistology, and molecular biology of extra-adrenal paragangliomas. Arch Pathol Lab Med 1989;113:1209-18.
21. Kliewer KE, Wen D-R, Cancilla PA, Cochran AJ. Paragangliomas: assessment of prognosis by histological, immunohistochemical and ultrastructural techniques. Human Pathol 1989;20:29-39.
22. Pacheco-Ojeda L, Durango E, Rodriguez C, Vivar N. Carotid body tumors at high altitudes; Quito, Ecuador, 1987. World J Surg 1988;21:856-60.
23. Parry DM, Li FP, Strong LC, Carney JA, Schoffenfeld D, Grufferman S, et al, Carotid body tumours in humans: genetics and epidemiology. J Natl Cancer Inst 1982;68:573-8.
24. Lack EE, Cubilla AL, Woodruff JM. Paragangliomas of the head and neck region: a pathologic study of tumours from 71 patients. Hum Pathol 1979;10:191-218.
25. Dickinson PH, Griffin SN, Guy AJ, McNeill IF. Carotid body tumors: a 30 years experience. Br J Surg 1986;73:14-6.
26. Arias-Stella J. Human carotid body at high altitudes [abstract] J Pathol 1969;55:82.
27. Edwards C, Heath D, Harris P, Castillo Y, Kruger H, Arias-Stella J. The carotid body in animals at high altitude. J Pathol 1971;104:231-79.
28. Saldana MJ, Salem LE, Traveza R. High altitude hypoxia and chemnodectomas. Hum Pathol 1973;4:251-63.
29. Bolande RP. The neurocristopathies. Hum Pathol 1974; 5:409-26.
30. Wong AJ, Ruppert IM, Eggleston J, Hamilton SR, Baylin SB, Vogelstein B. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science 1986;233:461-4.
31. Mash SP, Zhong LT, Liu Y, Roghani A, Edwards RH, Bredesen DE. The protooncogene bcl-2 inhibites apoptosis in PC12 cells. J Neurochem 1993;60:1183-6.
32. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119-28.
33. Askew D, Ashmun R, Simmons B, Cleveland J. Constitutive c-myc expression in IL-3 dependent myeloid cell line suppresses cycle arrest and accelerates apoptosis. Oncogene 1991;6:1915-22.
34. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992; 359:554-6.
35. Wagner AJ, Small MB, Hay N. Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol 1993;13:2432-40.
36. Vaux DL, Cory S, Adama JM. bcl-2 gene promotes haemopoietic cell survival and cooperaties with c-myc to immortalize pre B cells. Nature 1988;335:440-2.
37. Reed JC, Cuddy M, Haldar S, Croce C, Nowell P, Makover M, et al. BCL2 mediated tumorigenecity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. Proc Natl Acad Sci USA 1990;87: 3660-4.
38. Nunez G, Seto M, Seremetis S, Ferrero D, Grignani F, Korsmeyer SJ, et al. Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastyoid cells. Proc Natl Acad Sci USA 1989;86:4589-93.
39. McDonnell TJ, Nunez G, Platt FM, Hockenberry D, London L, Mckearn JP, et al. Deregulated Bcl-2-Ig transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 1990;10:1901-7.
40. McDonnell TJ, Korsmeyer SJ. Progression from lyphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991;349:254-6.
41. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
42. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, et al. bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989;57:79-88.
43. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, et al. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 1993;329:690-4.
44. Strasser A, Harris AW, Bath ML, Cory S. Novel primitive lymphoid tumours induced in transgenic mice by myc and bcl-2. Nature 1990;348:331-3.
45. Roncalli M, Coggi G. Oncogenes and neuroendocrine tumours. In: Polak JM, editor. Diagnostic histopathology of neuroendocrine tumours. Edinburgh: Churchill Livingstone, 1993:41-66.
46. Loke AL, Neckers SL, Chwab G, Jaffe EF. c-myc protein in normal tissue. Effect of fixation on its apparent subcellular distribution. Am J Pathol 1988;131:29-37.
47. Royds J, Sharrard RM, Wagner B, Polacarz SV. Cellular localisation of c-myc product in human colorectal epithelial neoplasia. J Pathol 1992;166:225-33.
48. Roux P, Blanchard JM, Fernandez A, Lamb N, Jeanteur P, Piechaczyk M. Nuclear localization of c-fos but not v-fos protein, is controlled by extracellular signals. Cell 1990;63:341-51.